Literature DB >> 3036906

Immunopathogenesis and treatment of myasthenia gravis.

A I Levinson, B Zweiman, R P Lisak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3036906     DOI： 10.1007/BF00915723

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  53 in total

1.  The immunohistology of the thymus in myasthenia gravis.

Authors:  M J Kornstein; J J Brooks; A O Anderson; A I Levinson; R P Lisak; B Zweiman
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

2.  Clinical and immunologic correlations in myasthenia gravis: measurement of con A stimulated suppressor cell activity.

Authors:  S M Koethe; A Cook; D P McQuillen; M P McQuillen
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

3.  Lymphocyte binding antibodies and suppressor cell activity in myasthenia gravis.

Authors:  R P Mischak; P C Dau
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.

Authors:  A R Pachner; F S Kantor
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

5.  Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.

Authors:  M Chilosi; A Iannucci; L Fiore-Donati; G Tridente; M Pampanin; G Pizzolo; M Ritter; M Bofill; G Janossy
Journal:  J Neuroimmunol       Date:  1986-05       Impact factor: 3.478

6.  Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis.

Authors:  A K Lefvert; R Pirskanen; E Svanborg
Journal:  J Neuroimmunol       Date:  1985-07       Impact factor: 3.478

7.  Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.

Authors:  J Newsom-Davis; N Willcox; L Calder
Journal:  N Engl J Med       Date:  1981-11-26       Impact factor: 91.245

8.  Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.

Authors:  D S Dwyer; R J Bradley; C K Urquhart; J F Kearney
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

9.  Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.

Authors:  A S Penn; D L Schotland; S Lamme
Journal:  Muscle Nerve       Date:  1986-06       Impact factor: 3.217

10.  Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.

Authors:  S Berrih; C Gaud; M A Bach; H Le Brigand; J P Binet; J F Bach
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330
View more
  14 in total

Review 1.  Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.

Authors:  Arnold I Levinson; Yi Zheng; Glen Gaulton; Decheng Song; Jonni Moore; C Hank Pletcher
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Phenotypic characteristics of thymic B lymphocytes in myasthenia gravis.

Authors:  B Zweiman; A I Levinson; R P Lisak
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

Review 3.  Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions.

Authors:  Michelle W Latting; Alison B Huggins; Douglas P Marx; Joseph N Giacometti
Journal:  Semin Plast Surg       Date:  2017-02       Impact factor: 2.314

4.  T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.

Authors:  A A Manfredi; M P Protti; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.

Authors:  E Meinl; W E Klinkert; H Wekerle
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

6.  Circulating antibodies against nicotinic acetylcholine receptors in chagasic patients.

Authors:  J C Goin; G Venera; M Biscoglio de Jiménez Bonino; L Sterin-Borda
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

Review 7.  The association of systemic lupus erythematosus and myasthenia gravis.

Authors:  G Vaiopoulos; P P Sfikakis; V Kapsimali; K Boki; P Panayiotidis; A Aessopos; G C Tsokos; P Kaklamanis
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

8.  Residues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice.

Authors:  P I Karachunski; N Ostlie; B M Conti-Tronconi; M Bellone
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

9.  Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects.

Authors:  L Moiola; P Karachunski; M P Protti; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 10.  The use of IVIG in neurological disease.

Authors:  A I Levinson
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.